Literature DB >> 17466915

Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts.

Ji-Yong Liu1, Jin-Hong Hu, Quan-Gang Zhu, Feng-Qian Li, Jing Wang, Hua-Jun Sun.   

Abstract

Matrine is a kind of alkaloid found in certain Sophora plants, which has been extensively used in China for the treatment of viral hepatitis, cancer, cardiac diseases and skin diseases (such as atopic dermatitis and eczema). It also has been confirmed that substance P (SP) and its receptor (neurokinin-1 receptor, NK-1R) are involved in the pathogenesis of inflammatory skin disorders. So the present study was designed to investigate the effect of matrine on the expression of NK-1R and cytokines production induced by SP in HaCaT cells (a human epidermal keratinocyte cell line) and dermal fibroblasts. In addition, cell viability was also evaluated. The results showed that matrine inhibited the expression of NK-1R in HaCaT cells and fibroblasts. SP induced the production of interleukin (IL)-1beta, IL-8, interferon (IFN)-gamma, and monocyte chemotactic protein (MCP)-1 in both cell types. Matrine 5-100 microg/mL had little effect on cell viability. It inhibited SP-induced IL-1beta, IL-8 and MCP-1 production in HaCaT cells and fibroblasts, while it increased the production of IFN-gamma in HaCaT cells. Both SP and matrine had no effect on the secretion of IL-6. These findings suggest that matrine may have potential treatment function on SP related cutaneous inflammation by inhibition of the expression of substance P receptor and regulation of the production of inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466915     DOI: 10.1016/j.intimp.2007.02.003

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  29 in total

1.  Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway.

Authors:  Shujun Zhang; Binglin Cheng; Hali Li; Wei Xu; Bo Zhai; Shangha Pan; Lei Wang; Ming Liu; Xueying Sun
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

2.  Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells.

Authors:  Bowen Zhao; Bin Li; Shuwei Bai; Ling Shen; Ruojin Ren; Jost B Jonas; Xiaolin Xu; Qingjun Lu; Qian Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-25       Impact factor: 3.117

3.  Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice.

Authors:  Dun Linglu; Li Yuxiang; Xu Yaqiong; Zhou Ru; Ma Lin; Jin Shaoju; Du Juan; Sun Tao; Yu Jianqiang
Journal:  Neurol Sci       Date:  2013-12-14       Impact factor: 3.307

4.  Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy.

Authors:  Jun-Qiang Zhang; Yu-Min Li; Tao Liu; Wen-Ting He; Ying-Tai Chen; Xiao-Hui Chen; Xun Li; Wen-Ce Zhou; Jian-Feng Yi; Zhi-Jian Ren
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

5.  Repurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in mice.

Authors:  Ali Mahzari; Xiao-Yi Zeng; Xiu Zhou; Songpei Li; Jun Xu; Wen Tan; Ross Vlahos; Stephen Robinson; Ji-Ming Ye
Journal:  Acta Pharmacol Sin       Date:  2018-07-06       Impact factor: 6.150

6.  Matrine inhibits IL-1β-induced expression of matrix metalloproteinases by suppressing the activation of MAPK and NF-κB in human chondrocytes in vitro.

Authors:  Shijin Lu; Xungang Xiao; Minghua Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 7.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

8.  Effects of matrine on JAK-STAT signaling transduction pathways in bleomycin-induced pulmonary fibrosis.

Authors:  Xiuqin Ma; Ruhua Chen; Xiufang Liu; Jin Xie; Keyun Si; Lirong Duan
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

9.  (6aS,11aR,11cS)-8-Sulfanylidene-2,3,5,6,6a,7,11,11a,11b,11c-decahydro-3a,7a-diaza-1H,4H-benzo[de]anthracen-3a-ium chloride hemihydrate.

Authors:  Liang Wang; Chun-Mei Zhang; Jun-Xiang Guo; Qiu-Ye Wu; Hong-Gang Hu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-18

10.  Antitumor activities of kushen: literature review.

Authors:  Mingyu Sun; Hongyan Cao; Lin Sun; Shu Dong; Yanqin Bian; Jun Han; Lijun Zhang; Shuang Ren; Yiyang Hu; Chenghai Liu; Lieming Xu; Ping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.